IL252221B - Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration - Google Patents

Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Info

Publication number
IL252221B
IL252221B IL252221A IL25222117A IL252221B IL 252221 B IL252221 B IL 252221B IL 252221 A IL252221 A IL 252221A IL 25222117 A IL25222117 A IL 25222117A IL 252221 B IL252221 B IL 252221B
Authority
IL
Israel
Prior art keywords
repair
transformed
self
aromatic compounds
pharmaceutical preparations
Prior art date
Application number
IL252221A
Other languages
English (en)
Hebrew (he)
Other versions
IL252221A0 (en
Original Assignee
Liminal Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liminal Biosciences Ltd filed Critical Liminal Biosciences Ltd
Publication of IL252221A0 publication Critical patent/IL252221A0/en
Publication of IL252221B publication Critical patent/IL252221B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/32—Phenylacetic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL252221A 2014-11-12 2017-05-10 Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration IL252221B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462078704P 2014-11-12 2014-11-12
PCT/CA2015/000572 WO2016074068A1 (en) 2014-11-12 2015-11-12 Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Publications (2)

Publication Number Publication Date
IL252221A0 IL252221A0 (en) 2017-07-31
IL252221B true IL252221B (en) 2022-04-01

Family

ID=55953490

Family Applications (1)

Application Number Title Priority Date Filing Date
IL252221A IL252221B (en) 2014-11-12 2017-05-10 Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Country Status (19)

Country Link
US (3) US10391073B2 (cg-RX-API-DMAC7.html)
EP (1) EP3217968A4 (cg-RX-API-DMAC7.html)
JP (1) JP6720169B2 (cg-RX-API-DMAC7.html)
KR (1) KR20170072352A (cg-RX-API-DMAC7.html)
CN (1) CN107106526B (cg-RX-API-DMAC7.html)
AR (1) AR102634A1 (cg-RX-API-DMAC7.html)
AU (2) AU2015345943B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017009899A2 (cg-RX-API-DMAC7.html)
CA (1) CA2967499C (cg-RX-API-DMAC7.html)
IL (1) IL252221B (cg-RX-API-DMAC7.html)
MX (1) MX381687B (cg-RX-API-DMAC7.html)
MY (1) MY187515A (cg-RX-API-DMAC7.html)
PH (1) PH12017500856A1 (cg-RX-API-DMAC7.html)
RU (1) RU2728782C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201703741TA (cg-RX-API-DMAC7.html)
TW (1) TWI723967B (cg-RX-API-DMAC7.html)
UY (1) UY36399A (cg-RX-API-DMAC7.html)
WO (1) WO2016074068A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201703579B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI742541B (zh) * 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
AU2015345943B2 (en) * 2014-11-12 2020-03-19 Liminal Biosciences Limited Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2289417C1 (ru) * 2005-04-15 2006-12-20 Равиль Шамилевич Мирхайдаров Способ биологического омоложения кожи
EP1953222A1 (en) * 2007-01-24 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Improvement of cell growth
EP2427416B1 (en) 2009-05-04 2016-03-09 Prometic Pharma Smt Limited Substituted aromatic compounds and pharmaceutical uses thereof
BRPI1015118A2 (pt) * 2009-05-04 2016-04-12 Prometic Biosciences Inc sais de ácido pentilfenilacético e usos farmacêuticos dos mesmos
ES2351005B1 (es) * 2009-07-10 2011-11-18 Consejo Superior De Investigaciones Científicas (Csic) Uso de anhidrasa carbónica ii para la elaboración de un medicamento.
US20130225683A1 (en) * 2010-10-27 2013-08-29 Prometic Biosciences Inc. Compounds and Pharmaceutical Compositions for Uses in Diabetes
CN105997967B (zh) 2010-10-27 2019-08-23 普罗米蒂克医药Smt有限公司 用于治疗癌症的化合物和组合物
PH12013500763B1 (en) * 2010-10-27 2018-07-04 Prometic Pharma Smt Ltd Phenylketone carboxylate compounds and pharmaceutical uses thereof
JP5388233B2 (ja) * 2011-01-19 2014-01-15 富士ソフト株式会社 再生軟骨の軟骨特性を評価する方法
WO2013021093A1 (es) * 2011-08-10 2013-02-14 Digna Biotech, S.L. Uso de la cardiotofina-1 para el tratamiento de enfermedades renales
TWI689490B (zh) 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療纖維化之經取代之芳族化合物及相關方法
TWI742541B (zh) 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
PL3203999T3 (pl) 2014-10-10 2020-07-27 Liminal Biosciences Limited Podstawione związki aromatyczne i kompozycje farmaceutyczne do zapobiegania i leczenia osteoporozy
SG11201702812PA (en) 2014-10-10 2017-05-30 Prometic Pharma Smt Ltd Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes
AU2015345943B2 (en) * 2014-11-12 2020-03-19 Liminal Biosciences Limited Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Also Published As

Publication number Publication date
EP3217968A4 (en) 2018-06-20
TW201618764A (zh) 2016-06-01
PH12017500856A1 (en) 2017-11-06
RU2017120401A (ru) 2018-12-13
CA2967499A1 (en) 2016-05-19
US10391073B2 (en) 2019-08-27
EP3217968A1 (en) 2017-09-20
MY187515A (en) 2021-09-24
TWI723967B (zh) 2021-04-11
ZA201703579B (en) 2018-08-29
WO2016074068A1 (en) 2016-05-19
MX381687B (es) 2025-03-13
UY36399A (es) 2016-06-30
MX2017006281A (es) 2017-08-14
US20170312237A1 (en) 2017-11-02
US20210085626A1 (en) 2021-03-25
AR102634A1 (es) 2017-03-15
RU2728782C2 (ru) 2020-07-31
AU2020204112A1 (en) 2020-07-09
AU2015345943B2 (en) 2020-03-19
BR112017009899A2 (en) 2018-01-16
AU2015345943A1 (en) 2017-06-01
JP6720169B2 (ja) 2020-07-08
CN107106526A (zh) 2017-08-29
KR20170072352A (ko) 2017-06-26
CA2967499C (en) 2023-01-17
SG11201703741TA (en) 2017-06-29
US20200078324A1 (en) 2020-03-12
JP2017533928A (ja) 2017-11-16
AU2020204112B2 (en) 2021-10-21
RU2017120401A3 (cg-RX-API-DMAC7.html) 2019-06-06
US10869849B2 (en) 2020-12-22
IL252221A0 (en) 2017-07-31
CN107106526B (zh) 2021-05-28

Similar Documents

Publication Publication Date Title
IL282304A (en) Topical pharmaceutical compositions
IL290823A (en) Pharmaceutical compositions for combination therapy
IL262831A (en) Medical implants and methods of preparation thereof
BR112016026378A2 (pt) formulações e métodos para tratamento com queratina
DK3191020T3 (da) Medicinsk/kirurgisk implantat
HUE053309T2 (hu) Új sók és gyógyászati készítmények gyulladásos betegségek kezelésére
BR112016015838A2 (pt) compostos heterocíclicos aromáticos, composição farmacêutica compreendendo os referidos compostos e produto de combinação
HUE054344T2 (hu) Gyógyászati készítmények AZD9291 tartalommal
MA50541A (fr) Formulations pharmaceutiques
BR112016027041A2 (pt) Combinações farmacêuticas para tratamento do câncer
BR112016018062A2 (pt) compostos terapêuticos, composição farmacêutica e usos
PL3381451T3 (pl) Kompozycja farmaceutyczna stosowana do redukcji zlokalizowanej tkanki tłuszczowej i zastosowanie kompozycji farmaceutycznej
DK3258938T3 (da) Phenothiazinanaloger som mitokondrie terapeutiske midler
MA42303A (fr) Formulations pharmaceutiques
LT2945642T (lt) Faktoriaus 1 baltymas, skirtas naudoti ligų gydymui arba prevencijai
BR112017019025A2 (pt) aplicadores de implante e métodos para administrar implantes.
BR112017013012A2 (pt) compostos de indenil, composições farmacêuticas e usos médicos destes
IL248779A0 (en) Pharmaceutical compositions for treating infectious diseases
IL251404B (en) Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
HUE043550T2 (hu) Eljárás állati szövetanyag fertõtlenítésére és sterilezésére
DK3313370T3 (da) Oftalmologisk farmaceutisk sammensætning
EP3337463A4 (en) PHARMACEUTICAL FORMULATIONS
DK3325027T3 (da) Medicinsk implantat
DK3129057T3 (da) Glykolipider og farmaceutiske sammensætninger deraf til anvendelse i terapi
IL251392B (en) Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes